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ABSTRACT
The endoplasmic reticulum is the site where integral membrane and secreted
proteins are synthesized and folded, and is also the site of synthesis of steroids, lipids,
and other macromolecules. While ER is found in most cell types, hepatocytes in
particular contain large amounts of both rough and smooth ER to facilitate their tasks,
which include lipoprotein assembly and secretion, cholesterol biosynthesis, and lipid
metabolism. As such, stress in the ER – and the cells’ ability to respond to it – plays a
key role in disease pathogenesis. In particular, hepatic steatosis, or fatty liver, is linked to
ER stress. However, if and how inherent variations in the resulting unfolded protein
response (UPR) affect the predisposition to ER stress-associated metabolic conditions,
including hepatic steatosis, remains to be established. By using genetically diverse deer
mice (Peromyscus maniculatus) as a model, we show that the profile of tunicamycininduced UPR in fibroblasts isolated at puberty varies between individuals and predicts
deregulation of lipid metabolism and diet induced hepatic steatosis later in life. Among
the different UPR targets tested, CHOP more consistently predicted elevated plasma
cholesterol and hepatic steatosis. Compared to baseline levels or inducibility, the
maximal intensity of the UPR following stimulation best predicts the onset of pathology.
Differences in the expression profile of the UPR recorded in cells from different
populations of deer mice correlate with the varying response to ER stress in altitude
adaptation. Upon analysis of gene expression in the livers, no differences in the
expression levels of various UPR-associated genes between steatotic and nonsteatotic

v

livers were recorded. Then we asked if there is a change in the relative levels of these
genes as compared to each other. While we did not note any changes to the coordination
of UPR genes among themselves, we did note that there was a loss of coordination
between ER stress genes and autophagy and metabolic genes, particularly hepatic lipase
(HL), but only in the livers of mice who had developed steatosis. Additionally, using rat
hepatoma cells which naturally express HL, we demonstrated that induction of ER stress
leads to the downregulation of HL alongside the upregulation of ER stress-induced genes.
Together, this data demonstrates the ability of tunicamycin-treated fibroblasts isolated
early in life to predict the propensity of an individual to develop hepatic steatosis; this
approach might also be useful for other conditions associated with ER stress, both
metabolic and otherwise. The results of the liver analysis imply that ER stress plays a role
in the expression of HL and potentially other important metabolic genes, and that the loss
of coordination of ER stress response with other cellular responses could be a more
important factor in the transition to disease than the levels of individual transcripts alone.
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CHAPTER 1: INTRODUCTION

The endoplasmic reticulum is the site where integral membrane and secreted
proteins are synthesized and folded, and is also the site of synthesis of steroids, lipids,
and other macromolecules (Jo et al., 2013; Rashid et al., 2015). Though the ER is a single
membrane system with a continuous intralumenal space, it consists of several distinct
domains, including the rough ER, smooth ER, and nuclear envelope, as well as other
areas of the system that contact other organelles within the cell (Voeltz et al., 2002).
These areas, though connected, perform distinct functions and have distinct protein
compositions which reflect those functions. For example, the nuclear envelope contains
proteins which bind to nuclear structures such as nuclear lamins and chromatin (Voeltz et
al., 2002). The rough ER, which is found in all eukaryotic cells, is distinct from other
areas of the ER due to the presence of ribosomes. These ribosomes occur on the surface
of the membrane and appear as small, pronounced dark spots on electron micrographs,
which makes the rough ER visually discernible. The presence of these ribosomes also
affects the structure; the RER is often less convoluted than the SER (Voeltz et al., 2002).
The rough ER is also necessary for protein translocation. The protein composition of the
smooth ER, on the other hand, varies – along with abundance and function – from cell
type to cell type. Liver cells, neurons, muscle cells, and steroid-synthesizing cells, all
have an abundance of SER, though the functions performed by the SER in each cell type
varies (Voeltz et al., 2002). For example, in the liver, the SER plays an important role in
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detoxifying hydrophobic substances. The SER includes the transitional ER, which
is responsible for packaging proteins for transport to the Golgi apparatus. This
transitional ER, unlike other areas of the SER, occurs in all eukaryotic cells (Voeltz et al.,
2002).
Under normal conditions, the process of protein folding is carefully controlled and
performed under conditions which facilitate proper folding and discourage misfolding of
polypeptides and the formation of protein aggregates. The process of protein folding is
mediated by other proteins called chaperones, which serve to ensure that all synthesized
proteins are properly folded (Rashid et al., 2015). Any proteins that are irreparably
misfolded are targeted for degradation by the proteasome. Under physiological
conditions, there exists a balance between the levels of unfolded proteins and the levels
of chaperones present to fold them which results in the maintenance of homeostasis.
However, under conditions of disease or environmental stress, excessive
polypeptide production can overwhelm the capabilities of the protein folding machinery
of the ER, leading to the accumulation of unfolded, misfolded, and aggregated proteins
(Lee et al., 2015; Rashid et al., 2015). If these aberrant polypeptides accumulate to toxic
levels, it places stress on the ER, compromising normal physiological function and
ultimately cell survival. The cell attempts to alleviate this stress via the Unfolded Protein
Response, or UPR (Lee et al., 2015) which depending on the duration and the intensity of
the stress may have multiple outcomes ranging from pro-survival to pro-apoptotic.
In mammalian cells, this response occurs through three distinct, but parallel,
signal pathways; one mediated through inositol-requiring protein 1a (IRE1a), one
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mediated through protein kinase-like endoplasmic reticulum kinase (PERK), and another
mediated through activating transcription factor 6 (ATF6) (Jo et al., 2015; Lee et al.,
2015; Walter and Ron, 2011), all of which are intracellular receptors located in the ER.
Under normal conditions, each of these sensors is bound to BiP, a chaperone which
preferentially binds to unfolded proteins, if they are present. When unfolded proteins are
absent, BiP remains bound to the sensors, suppressing their activity. Only when aberrant
polypeptides begin to accumulate does BiP detach from the three sensors, allowing them
to activate and initialize the UPR.
Perhaps the most strongly conserved and best studied of these pathways begins
with IRE1, which is found even in yeast, which lack the other signaling arms of the UPR
found in mammalian cells (Walter and Ron, 2011). Under ER stress conditions, IRE1
oligomerizes, leading to conformational changes which activate its ribonuclease (RNase)
domain (Walter and Ron, 2011). Active IRE1 cleaves the mRNA for X-box Binding
Protein 1 (XBP1), which are then ligated into an alternately spliced form which is
translated into the active form of XBP1, XBP1s (Walter and Ron, 2011). This
transcription factor activates genes related to lipid biosynthesis, to enable expansion of
the ER, and helps to regulate the production of components of the ER-associated
degradation system (Walter and Ron, 2011).
The transcription factor ATF6 is initially synthesized as a 90kDa ER
transmembrane protein. Under conditions of ER stress, ATF6 is packaged into transport
vesicles, which are delivered to the Golgi apparatus. Here, ATF6 is cleaved: first by site1 protease (S1P), which removes the luminal domain, and then by site-2 protease (S2P),
which removes the transmembrane anchor, producing a free-floating, 50kDa form of
3

ATF6 (Walter and Ron, 2011). This active form of ATF6 then moves to the nucleus,
where it activates UPR target genes, including BiP, GRP94, and protein disulfide
isomerase (PDI) (Walter and Ron, 2011).
The last of the three sensors is PERK; like IRE1, PERK oligomerizes under ER
stress conditions (Walter and Ron, 2011). When oligomerized, its kinase activity is
produced, and it autophosphorylates itself and the translation initiation factor Eukaryotic
translation initiation factor 2 subunit 1 (eIF2a). This prevents the formation of Eukaryotic
initiation factor 2 (eIF2), leading to cessation of the majority of translational activity and
reduction of the protein folding load (Walter and Ron, 2011). However, those mRNAs
which possess a short open reading frame in their 5’ untranslated regions continue to be
translated, even with the reduction of eIF2. Among these is the mRNA for Activating
transcription factor 4 (ATF4), which drives the expression of DNA damage-inducible
transcript 3 (Ddit3, also known as C/EBP homologous protein, or CHOP) and protein
phosphatase 1 regulatory subunit 15A (PPP1R15A, also known as growth arrest DNA
damage–inducible 34, or GADD34). CHOP, in great enough abundance, will activate
genes relating to apoptosis. This means that the PERK pathway is capable of both prosurvival and pro-apoptotic signaling (Walter and Ron, 2011).
During minor to moderate ER stress, the three arms of the UPR work in concert to
promote the restoration of homeostasis within the ER. Pro-survival UPR signaling leads
to several outcomes. One is the cessation of protein production; the translation of most
transcripts ceases, with the exception of those for chaperones and other UPR-related
genes. In addition, any polypeptides that are irreparably misfolded are translocated to the
cytosol and targeted for degradation by the proteasome, a process referred to as ER4

associated degradation (ERAD) (Meusser et al., 2005). Finally, it signals for the
production of lipids in order to facilitate the expansion of the ER, to accommodate the
excess proteins and the chaperones that will be needed to fold them.
However, if ER stress persists for too long or becomes too severe, then the UPR
becomes proapoptotic and signals for the permeabilization of the mitochondrial
membrane, leading to the release of cytochrome c and subsequent activation of
executioner caspases (Merksamer et al., 2010). The exact trigger for the switch from prosurvival to pro-apoptotic signaling is still under investigation, but there is evidence that
varying states of IRE1 oligomerization may play a role – IRE1 oligomers will
disassemble and be dephosphorylated after a period of time, even if ER stress has not
been mitigated, rendering IRE1 signaling inactive and potentially serving as a signal that
the ER stress cannot be resolved (Li et al., 2010). UPR-induced apoptosis is regulated by
the Bcl-2 family of proteins, which is divided into three groups containing both proapoptotic and anti-apoptotic factors. One of these groups, the BH3-only proteins, contains
11 different proteins, four of which are implicated in UPR-induced apoptosis: Puma,
Noxa, Bid and Bim (the last of which CHOP has been shown to increase the transcription
of). These proteins are transcribed and translated – or if already translated, activated – in
response to ER stress and go on to suppress the anti-apoptotic Bcl-2 family proteins.
Additional evidence also suggests that, depending on cellular context, mitogen-activated
protein kinase (MAPK) c-Jun NH2-terminal kinase (JNK) signaling can also lead to the
suppression of anti-apoptotic Bcl-2 family members, further adding to the cell death
signal. (Merksamer et al., 2010)
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Because the ER is a wide-reaching membrane system with connections to
multiple organelles, stress of the ER ultimately affects the functioning of the entire cell.
Though the UPR is initially intended to be a pro-survival mechanism, if ER stress persists
for too long or becomes too extreme, the UPR becomes pro-apoptotic, and the stressed
cell dies. Under ideal conditions, the pro-apoptotic response would be beneficial in the
elimination of dysfunctional cells. Under stress conditions, however, widespread ER
stress and cell death can lead to the development of disease.
ER stress is linked to many diseases, some of which are or can become quite
severe. ER stress is linked not only to cardiovascular diseases (Minamino et al., 2010),
inflammatory conditions such as inflammatory bowel disease (Kaser et al., 2008), and
even neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases
(Hoozemans et al., 2012), but it plays an especially prominent role in the development of
metabolic diseases, such as Type II diabetes and Nonalcoholic fatty liver disease
(NAFLD). In general, ER stress is associated with the onset of pathology through the
excessive accumulation of misfolded proteins that can form aggregates, as in the case of
common neurodegenerative diseases. This excessive protein aggregation becomes toxic
and can lead to cell death.
In the pancreatic islets, the link between ER stress and pathology proceeds as
follows: The efficient and sufficient production of the peptide hormone insulin is
essential for the maintenance of glucose homeostasis. Insulin is synthesized and folded in
the ER of pancreatic β-cells, which are found in clusters of cells referred to as Islets of
Langerhans. When blood glucose levels are high, β-cells secrete insulin into the
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bloodstream, where it performs its task of promoting the uptake of glucose by cells
particularly by the liver, adipose tissue, and skeletal muscle.
At conditions of sustained hyperglycemia β-cells must try to produce enough
insulin to maintain blood glucose homeostasis, and for this reason are particularly
susceptible to ER stress (Lee et al., 2015). Insulin resistance, in which cells lose their
sensitivity to insulin and do not take up as much glucose from the bloodstream, leads to
inflated blood glucose levels, which in turn stimulate additional insulin production and
secretion. At first, healthy islets will respond to metabolic stress – brought on by obesity
and nutritive excess – by increasing the proliferation of the β-cells to accommodate the
increasing demand (Back et al., 2011). However, as insulin resistance worsens, it
becomes necessary for the β-cells to produce additional insulin to counteract the
resistance. Eventually, this reaches a point where the additional demand exceeds the
capacity of the cell to fold the additional proteins, leading to ER stress and activation of
the UPR. If not resolved, the UPR eventually shifts from pro-survival to pro-apoptotic,
leading to the death of β-cells and reduction of beta cell mass. Unfortunately, this only
compounds the problem; as β-cells begin to die off, the remaining population must try to
compensate for the lost cells, becoming more stressed in the process and ultimately dying
themselves. This leads to a decrease in insulin production and the development of type II
diabetes. In type I diabetes, it is the autoimmune-mediated destruction of the β-cells
which ultimately leads to a similar cascade of attempted compensation followed by ER
stress and cell death.
Because hepatic tissue is one of the tissues most responsive to insulin, insulin
resistance also has a great effect on the liver, which is responsible for carrying out many
7

important metabolic functions. These include the assembly and secretion of lipoproteins,
cholesterol biosynthesis, metabolism of lipids and foreign compounds, and production
and secretion of plasma proteins (Malhi and Kaufman, 2011). These functions are all
performed in the ER, and as such, hepatocytes contain large amounts of both rough and
smooth ER to facilitate their tasks. Because the ER is such an important part of liver
function, and because the liver’s functions are so critical to survival, hepatocytes must be
able to quickly and effectively deal with ER stress. The inability of hepatocytes to
alleviate ER stress generally leads to dysfunction and disease. ER stress of the liver can
be caused by overnutrition, leading to the buildup of lipids in various other tissues,
including the liver (Han and Kaufman, 2016). This leads to dyslipidemia and the
development of hepatic steatosis, the first stage of NAFLD. Though hepatic steatosis is
itself rather benign, it can exacerbate the problem by promoting further stress, and if left
untreated, will progress to nonalcoholic steatohepatitis (NASH). During NASH, the liver
becomes inflamed, and hepatocytes begin to accumulate damage in the form of continued
ER stress, mitochondrial dysfunction, oxidative stress, and numerous other stressors and
stress pathways. Eventually, the liver becomes fibrotic from the buildup of scar tissue;
this damage cannot be reversed, only stopped, but if it continues, the condition advances
to cirrhosis of the liver, liver failure, and potentially hepatocellular carcinoma.
While the exact contribution of ER stress and the UPR to the development of
NAFLD isn’t yet fully understood, we do know that it plays a role even in the earliest
stage of the disease: simple hepatic steatosis. In fact, the relationship between ER stress
and hepatic steatosis is bilateral in nature, with each promoting the development or
progression of the other (Dara et al., 2011). During hepatic steatosis, excess triglycerides
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– often dietary in origin – accumulate in the cytoplasm of the hepatocytes. While initially
benign, this can easily progress to the more severe NASH if not remediated. Interestingly,
it has been found that the mediators of ER stress – IRE1, ATF6, and PERK – are capable
of regulating lipid stores in the liver, each through their own activities. The IRE1-XBP1
pathway, for example, has been demonstrated to be critical for maintaining lipid
homeostasis in stressed hepatocytes (Zhang et al., 2014). Hepatocyte-specific deletion of
IRE1 in mice leads to the development of severe steatosis upon challenge with an ER
stress-inducing agent; plays a role in the assembly and secretion of hepatic VLDLs;
activating genes related to de novo lipogenesis; and upon disruption of ER homeostasis,
is additionally important to the secretion of apolipoprotein (Zhang et al., 2014). ATF6,
meanwhile, is important in regulating the accumulation of lipids under stress. It has been
shown to bind to and antagonize Sterol regulatory element-binding protein 2 (SREBP2),
thereby acting to suppress the expression of lipogenic genes and thus, the accumulation
of lipids (Zhang et al., 2014). The PERK-eiF2α-ATF4 pathway, on the other hand, can
contribute to the development of hepatic steatosis; compromising this pathway leads to a
reduction in the incidence of hepatic steatosis in high-fat diet-fed animals (Zhang et al.,
2014). A study performed by Zhang et al. (2014) additionally demonstrated that ER stress
is capable of inducing hepatic inflammation via activation of inflammasomes, protein
complexes which promote an inflammatory response, and ultimately promotes the
development and progression of NAFLD. Given the evidence showing the role of ER
stress in the development of this condition, it stands to reason that individual differences
in ER stress susceptibility and response would lead to differences in susceptibility to ER
stress-related conditions. Because the damage to the liver from NAFLD can become
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severe to the point of lethality, it is important to understand the complex interactions
occurring between the UPR and other pathways, as well as characterizing the relative
abundance of transcripts and proteins in the cell. During disease progression, the
transcriptional profile of the cell changes, with certain genes being upregulated while
others are suppressed. During this process, it is possible that genes belonging to the same
transcriptional networks are co-regulated, regardless of the disease status and the
individual genes’ abundance. Considering that disease signifies deviation from cellular
homeostasis, it is possible that the genes that are more relevant to the disease will abolish
this coordination, a consequence of the loss of homeostasis. These questions cannot be
addressed by using regular inbred mice and to be answered they require genetically
diverse models at which abundance of transcripts may be variable, yet coordination in
gene expression likely persists.
There are many factors which contribute to one’s likelihood of developing
diseases such as hepatic steatosis. Increasingly, we are realizing the importance of
genetics in the development of diseases such as NAFLD. There are a number of genetic
mutations, affecting various pathways, which can lead to the development of NAFLD
even in the absence of dietary triggers. Some lead to impairments in hepatic triglyceride
export, such as the rare condition Abetalipoproteinemia, in which a mutated microsomal
triglyceride transfer protein (MTTP) subunit leads to absence of ApoB-containing
lipoproteins, or Familial hypobetalipoproteinemia, caused by a mutation in ApoB itself.
In both cases, the mutations lead to an inability, or impaired ability, to export
triglycerides from the liver, thus producing hepatic steatosis among other symptoms
including fat-soluble vitamin deficiencies (Hooper et al., 2011). A mutation in solute
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carrier family 25, member 13 (SLC25A13) leads to citrullinemia type II, one symptom of
which is the enhancement of de novo lipogenesis resulting in hepatic steatosis (Hooper et
al., 2011). Familial lipodystrophies caused by mutations in Peroxisomal proliferatoractivated receptor γ (PPARG) or the nuclear lamin A/C gene LMNA, in which the patient
is unable to produce or maintain healthy adipose tissue, are associated with numerous
metabolic abnormalities including hyperinsulinemia and hypertriglyceridemia, alongside
hepatic steatosis. Other mutations can lead to impairments in hepatic fatty acid storage
and breakdown, which also promote hepatic lipid accumulation and thus development of
steatosis.
However, the vast majority of the cases of NAFLD occur without any notable
genetic anomalies like those mentioned above; nonetheless, there is still variation in the
likelihood of developing the disease. In a study of white, African-American, and
Hispanic populations, which controlled for age and BMI, it was observed that the
Hispanic population was most likely to present with hepatic steatosis, while AfricanAmericans were least likely to do so, with the differences reflecting variability in
abdominal fat accumulation. Interestingly, further analysis of this same group further
demonstrated that African-Americans developed a higher degree of insulin resistance,
while still maintaining lower triglyceride levels (Hooper et al., 2011). In this case, the
differences are not caused by abnormal proteins, but by small variations in normal
proteins which have just enough of an effect to slightly increase or decrease one’s
chances of developing disease. Of these, a single nucleotide polymorphism (SNP) in the
gene for Patatin-like phospholipase domain containing 3 (PNPLA3), also called
adiponutrin, is of particular note. While many different SNPs in many different genes
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have been loosely connected to hepatic steatosis, only SNPs in PNPLA3 have been
strongly associated with variations in hepatic fat content across ethnicities, with similar
results having been replicated and corroborated in numerous studies over time. Also of
note is the fact that this SNP was most common in participants of Hispanic descent, who
are also most likely to develop NAFLD (Hooper et al., 2011). Other genes in which SNPs
have been associated with NAFLD include MTTP, diacylglycerol acyltransferase
(DGAT2), and phosphatidylethanolamine N-methyltransferase (PEMT), as well as
various genes affecting insulin resistance and/or sensitivity, oxidative stress response,
immunity, and other processes (Hooper et al., 2011).
Nonetheless, despite recognition of this sort of genetic variability as a contributor
to disease susceptibility, the most common model of human disease continues to be the
standard laboratory mouse, Mus musculus. Though there is variation between different
strains of laboratory mice, individual strains have been highly inbred for years to various
ends, such as eliminating genetic variants which might affect researchers’ experimental
results, or selection for various traits, including disease conditions and susceptibilities,
coat colors, docility, and ease of handling. The genetic homogeneity of the laboratory
mouse makes it a reliable model for mechanistic studies, and it has been the go-to system
for the majority of medical and pharmaceutical research (Havighorst et al., 2016). It is
traditional in research to utilize genetically similar mouse models due to this reduction in
variables. However, despite its power in providing robust results when selected and
specific traits and genetic variants are being evaluated, it has limited value in the context
of naturally existing genetic variation. Unfortunately, this means that for studies
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involving natural genetic variability between animals, the mouse model’s usefulness is
limited (Havighorst et al., 2016).
The human population, unlike laboratory mice, exhibits a great deal of genetic
diversity. This diversity occurs in genes not just for hair or eye color, but in genes for
critical components of various cellular pathways. Variations in these genes may not be
detectable by means other than genetic screening and other similar technologies, but they
still may play important roles in disease development. As an example of such variation,
the three different alleles of apolipoprotein E (APOE) are associated with differing
likelihood of developing diseases such as atherosclerosis, Parkinson’s disease,
Alzheimer’s disease, and can even affect one’s immune system and therefore ability to
fight infections. These consequences can be debilitating and even deadly, but the
different alleles of APOE vary by only two amino acids and would likely not have much
other drastic effect on the individual outside of relevant challenges (Moretti et al., 2005).
Small but impactful variations such as this exist throughout the human genome, and only
a small fraction of these variations have been characterized.
An additional limitation of the conventionally used inbred mouse models is
related to the types of genomic manipulations that are performed that are not always
representative of what occurs in nature and may occasionally be misleading. The vast
majority of the experimental evidence that causatively associates ER stress with hepatic
steatosis as well as with other diseases involves the genetic ablation, usually in specific
tissues, of the particular genes under investigation and subsequently the assessment of the
phenotypes that develop. Such studies showed that the loss of function of particular UPR
targets may result in the onset of steatosis underscoring the protective role of the UPR in
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disease development (Zhu et al., 2015; Yamamoto et al., 2010; Ji et al., 2011; Chen and
Zhu et al., 2014; Chen and Tseng et al., 2014). Alternatively, other studies identified the
pro-lipogenic role of certain UPR targets such as CHOP (Rutkowski et al., 2008),
underscoring the complex integration of the various components of the UPR in the
development of steatosis.
These studies, although they clearly establish correlation between specific UPR
genes and disease, suffer from the fact that genetic ablation of a single loci is rather
irrelevant biologically and may trigger phenotypes that are qualitatively distinct from
those occurring naturally, from hypomorphic versions of UPR-associated genes. Indeed,
it is not uncommon for different quantitative inputs to provide distinct qualitative outputs,
complicating data interpretation (Garcia and Phillips, 2011). In addition, experimentation
and disease modeling in genetically homogenous, inbred mice, although a superior choice
for mechanistic studies, is inadequate in addressing questions regarding the regulation of
ER stress response in diverse populations which exhibit varying levels of UPR among
individuals (Wade and Daly, 2005). For example, while UPR is a rather global response
involving the simultaneous activation of many different transcripts, its deregulation is
commonly studied at the level of overexpression of specific chaperones upon exposure to
the stress stimulus without examining if, aside from expression levels of a single target,
the relative levels as compared with other UPR targets are also associated with
pathogenicity (Hetz et al., 2013; Gardner et al., 2013). Such questions cannot be
answered by using inbred mice as a model at which any variation in the response
recorded is attributed to stochastic differences during the course of the experiment, while
inherent variation could not be held accountable.
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The deer mouse, Peromyscus maniculatus, is a genetically diverse model
organism whose use in medical research is currently restricted due to a lack of available
tools and the presence of extra variables due to their diversity (Havighorst et al., 2016).
Native to a large part of North America, the deer mouse has been used extensively in
other areas of research, such as animal behavior, coat color genetics, and ethanol
metabolism (Havighorst et al., 2016). Captive stocks of wild-type deer mice kept at the
Peromyscus Genetic Stock Center are outbred rather than inbred, meaning that they still
possess gene variants which affects individual animals’ responses to studies, either subtly
or overtly. This diversity more closely reflects that of human populations, making the
deer mouse an ideal candidate for exploring inherent variation between individuals and
how that variation may affect disease development or progression.
The overarching theme of the present Thesis was to model for the first time the
UPR in an outbred, naturally occurring wild type population. Specifically, our goal has
been to explore and characterize the relationship between ER stress and disease
susceptibility and progression in a genetically diverse system. We sought to explore the
outcomes of varying UPR in naturally existing populations, and for this chose to use deer
mice as our model. In this genetically diverse system, naturally existing quantitative
variation in the UPR, rather than the qualitative changes typically induced in mice – such
as genetic deletion or forced overexpression of specific genes of interest – could be
studied more effectively. Additionally, we asked if the expression of different UPR
components and genes associated with lipid metabolism is correlated in the liver upon
administration of a steatosis-inducing diet and whether upon prolonged high-fat diet
administration this coordination is lost, maintained, or enhanced.
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The use of deer mice as a model means that experiments are performed on a
population more comparable to human populations in terms of genetic diversity. The
combination of in vitro and corresponding long-term in vivo studies performed here has
not been done in a genetically diverse model organism until now, and this approach has
led to insight that is more directly relevant to genetically diverse human populations.
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CHAPTER 2: RESULTS

THE PROFILE OF THE UPR VARIES IN FIBROBLAST CULTURES OF DEER
MICE
Initially, we sought to explore if and to what extent the UPR profile differs among
individual animals. To address this, primary fibroblast cultures (<7 passages) were
established during puberty from a genetically diverse population of P. maniculatus
(n=85, 43 males and 42 females) and the UPR profile was assessed after exposure of
cultured cells to tunicamycin at 5ug/mL for 5 hours. This dosage and duration of
treatment has been determined in preliminary studies at which different treatment periods
and amounts of tunicamycin were tested. As shown in Figure 2.01, high variation in the
UPR profile was detected as monitored by the baseline levels (upper panel), induction
levels following tunicamycin exposure (lower panel), and maximal levels (middle panel),
of a roster of UPR-associated genes that included chaperones BiP, GRP94 and calnexin
and the ER stress-associated transcription factor CHOP. Since tunicamycin is a rather
global activator of ER stress and an inducer of the UPR (Li and Lee, 1991), we expected
to record a positive correlation in the expression of different UPR-related genes in the
same individuals. Indeed, a strong positive correlation was identified for all pairwise
comparisons (P≤0.0001, Pearson’s) when maximal levels of expression in tunicamycin–
treated cells were considered (Figure 2.02). Those included clockwise from top (Figure
2.02)
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Figure 2.01: Expression of BiP, GRP94, calnexin and CHOP in primary fibroblasts
isolated at puberty from P. maniculatus (n=85, 43 males and 42 females). Expression
prior (baseline), after tunicamycin exposure (maximal) at 5ug/mL for 5 hours, and
ratio max vs. baseline (inducibility) is shown. All expression values had been
normalized in relation to GAPDH. Each bar represents a different animal. (Adapted
with permission from Havighorst et al., 2019)
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Figure 2.02: Coordinated expression of UPR-associated genes in primary fibroblasts
of P. maniculatus. Pairwise comparisons in expression (arbitrary units) of ER
stress-related genes after exposure of cells to tunicamycin. R values from Pearson’s
correlation and P values are shown. All expression values had been normalized in
relation to GAPDH. (n=85, 43 males and 42 females) (Adapted with permission
from Havighorst et al., 2019)
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BiP vs GRP94, GRP94 vs Calnexin, GRP94 vs CHOP, Calnexin vs CHOP, Calnexin vs
CHOP, CHOP vs BiP, and BiP vs Calnexin. However, when either the baseline levels of
expression of untreated cells or fold induction (defined as the ratio of maximal to
baseline) after tunicamycin treatment were analyzed, correlation was decreased and
reached significance only in specific pairwise comparisons (Figure 2.03). Therefore, we
concluded that the maximal levels of UPR-associated gene expression likely give the
most information in terms of UPR induction, and that the intensity of the UPR ultimately
reflects a generalized systemic response that transcends different branches of the UPR
rather than a response of specific UPR targets. The fact that maximal expression (after
tunicamycin treatment) was more informative may also be related to the fact that it
reflects the maximal capacity for UPR induction, while baseline levels may reflect
expression in cells that despite the absence of tunicamycin may have undergone some
stress. The systemic nature of this response is also supported by the observation that the
expression profile of UPR genes in primary fibroblasts from different animals was similar
in thapsigargin and tunicamycin treated cells, despite that they induce ER stress by
alternate mechanisms (Figure 2.04). In line with this is the fact that independent
preparations of fibroblasts from the left or the right ear rendered similar results for
GRP94, BiP and calnexin (Figure 2.05). Some variation was detected for CHOP which
however was insufficient to alter considerably the overall magnitude of the response
when assessed in comparison with the whole group of animals tested. This variation in
CHOP is probably related to the fact that CHOP is proapoptotic and therefore is likely
subjected to strong selective pressure during culture of primary cells (Figure 2.05).
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Figure 2.03: Pairwise comparisons in expression (arbitrary units) of ER stress-related genes, either at baseline levels
of expression or fold induction. R values from Pearson’s correlation and P values are shown. All expression values
had been normalized in relation to GAPDH. (n=85, 43 males, 42 females) (Adapted with permission from
Havighorst et al., 2019)

Figure 2.04: The expression of BiP, GRP94, Cnx and CHOP in fibroblasts from
different animals exposed to Tunicamycin (TM) or Thapsigargin (TG). Exposure to
TG was performed at 1μΜ for 5h. Vertical bars indicate SEM from 2 replicas. Animal
number is indicated. (Adapted with permission from Havighorst et al., 2019)
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Figure 2.05: UPR expression profile in different fibroblast preparation isolated from
the left (LT) or right (RT) ear of different animals. Vertical bars indicate SEM from 2
replicas. Animal number is indicated. (Adapted with permission from Havighorst et
al., 2019)
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Noteworthily, this responsiveness of fibroblasts to tunicamycin was progressively
abolished because at later passage the inducibility decreased (Figure 2.06).
Comparison between males and females showed no significant difference in the
profile of the UPR. Yet, a trend for higher intensity was detected in the former. In males,
the expression of at least 2 UPR genes fell in the top 25th percentile in 16 out of 43
specimens, as compared to 10 out of 42 in females (P=0.15). These results are consistent
with previous studies that demonstrate the protective effect of estrogen signaling against
ER stress (Andruska et al., 2015; Kooptiwut et al., 2014).
In order to further investigate the relationship between baseline levels, maximal
expression after tunicamycin treatment, and levels of induction (ratio of maximal to
baseline), we investigated whether maximal and baseline expression were correlated for
the different ER stress targets tested. This analysis showed that for BiP (P<0.0001),
GRP94 (P<0.0001) and CHOP (P=0.0005), but not for calnexin, the maximal levels
correlated with the baseline levels (Figure 2.07a). This indicates that baseline levels of
BiP, GRP94 and calnexin proportionally affect their levels of induction after tunicamycin
administration. In calnexin (P=0.01) and CHOP (P=0.0029), but not for BiP (P=0.81) and
GRP94 (P=0.53), a reverse correlation between baseline levels and inducibility was
detected (Figure 2.07b). These observations imply that during stress, different UPR genes
display a distinct mode of regulation. In some, exemplified by GRP94 and BiP, maximal
levels are proportional to the baseline levels implying the existence of a not highly
variable degree of induction. For others such as calnexin, it appears that inducibility is
negatively associated with the baseline and positively with maximal levels, indicating
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Figure 2.06: Comparison in the expression profile of BiP, GRP94, CNX and CHOP in
fibroblasts analyzed at early (2-3) or late (5-6) passage. Vertical bars indicate SEM
from 2 replicas. Animal number is indicated. (Adapted with permission from
Havighorst et al., 2019)
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Figure 2.07: Pairwise comparisons between the baseline expression vs. maximal
(a) and baseline expression vs. inducibility (b) expression for BiP, GRP94,
calnexin and CHOP. R values and P values from Pearson’s correlation are
shown. All expression values had been normalized in relation to GAPDH. (n=85,
43 males and 42 females) (Adapted with permission from Havighorst et al.,
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that the expression prior to stress determines the extent of stimulation. CHOP follows
both modes of regulation.
CHAPERONE INDUCIBILITY IS VARIABLY CORRELATED WITH BLOOD
GLUCOSE
Because ER stress is associated with multiple pathologies, we next addressed the
question of whether the variability we observed would lead to differences in disease
susceptibility between individuals. Of particular interest was the animals’ susceptibility
to diabetes, since the UPR plays such a prominent role in its pathogenesis. To address
this, we administered a high-fat, high-sucrose diet, designed to induce diabetes, to 3month-old male and female animals whose UPR profiles had been characterized at
weaning. For six months, we monitored the animals’ blood glucose levels and weights,
first weekly and then biweekly. Though the animals never became diabetic, we did
observe correlations between blood glucose levels and UPR gene expression, particularly
with GRP94 and Calnexin (Figure 2.08). While there was no correlation between GRP94
and pre-HFD blood glucose levels, GRP94 high responders initially respond robustly to
dietary challenge, and are able to regulate their blood sugar. While low responders
experienced a spike in blood sugar on Day 7, high responders maintained a stable blood
glucose, negatively correlating GRP94 expression and blood glucose (p=0.02). This
protection, however, begins to taper off until the correlation is reduced below
significance by Day 35 (p=0.31). By Day 70, however, the two are once again correlated,
but positively this time (p=0.01), indicating that the adaptive value of high GRP94
response is high in the short term, but is reduced over the long term to the point that it
may actually exacerbate the problem. Unlike GRP94, we observed a positive correlation

27

Figure 2.8: Correlation between GRP94/Calnexin and blood glucose shifts over time.
GRP94 High responders respond robustly to challenge, but this response is exhausted.
Calnexin High responders have higher overall blood glucose when unchallenged, but
are better able to respond to challenge. Like with GRP94, the adaptive value of high
response is short-lived.
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between Calnexin and blood glucose at Day 0; Calnexin high responders have higher
overall blood glucose when unchallenged. This correlation had become negative by day 7
(p=0.14) and had fully reversed by Day 14 (p=0.03), but even this correlation diminished
by days 28 (p=0.21) and 35 (p=0.47), and remained poor for the duration of the
experiment; the correlation between Calnexin and blood glucose is ultimately lost under
prolonged metabolic stress.
THE OVERALL RESPONSE OF INDIVIDUAL ANIMALS IS CORRELATED WITH
GLYCEMIC VARIATION
We noted correlations between individual genes and blood glucose levels;
however, this does not take into account the entire UPR profile of the animal. In order to
do so, animals were classified as overall high, median, or low responders based on the
number of genes that were highly expressed (0-4). This method only considers the
number of genes being highly expressed; it does not account for specific gene
combinations which may also be correlated with particular phenotypes. While our sample
size was not large enough to allow for proper exploration of gene combinations, we
found that animals which were overall low responders exhibited a greater week-to-week
variation than overall high responders, which showed very little week-to-week variation
(Figure 2.09a). Median responders’ week-to-week variation fell between that of the low
and high responders, suggesting that the overall level of response is indicative of the
animals’ ability to regulate its blood sugar. While high responders didn’t exhibit great
fluctuations from week to week, their average blood glucose – like those of the low and
median responders – did rise 20 points over the six months’ duration of the experiment
(Figure 2.09b).
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Figure 2.09: Visualization of week to week glycemic variance, separated by UPR
profile, (a) represented in terms of % change, (b) represented as average blood
glucose, and (c) represented as variance.
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PLASMA LIPID LEVELS CORRELATE WITH THE UPR PROFILE OF PUBERTAL
FIBROBLASTS EX VIVO
Next, we wanted to test if the profile of UPR recorded in fibroblasts ex vivo
possesses predictive value for the onset of a chronic pathology linked to ER stress. In
view of the role of ER stress in the development of metabolic disorders, we studied the
association of inherent variation in UPR in primary cultures ex vivo with lipid levels prior
to or after administration of high fat diet. Thus, we measured total cholesterol, low
density lipoprotein (LDL) and high density lipoprotein (HDL) in the plasma of adult
animals aged 4-5 months old, before and after short term (2-week) administration of a
high fat/sucrose diet. We postulated that during this short time-period of high-fat dietary
intake, no major histopathological damage would occur in the liver, and therefore the
plasma lipid levels would directly reflect the result of lipid metabolism rather than of
liver dysfunction. A summary of this analysis is shown in Figure 2.10a while selected
examples of correlation between total cholesterol (chol) before (pre) or after (post) highfat diet administration and BiP, GRP94 and CHOP are shown in Figure 2.10b. Before
high- fat diet administration all UPR target genes tested showed positive correlation with
the lipid levels in the plasma suggesting that baseline plasma lipid levels directly follow
the propensity for individual UPR changes as recorded in primary cell cultures
established early in life. When this association with plasma lipid levels was specifically
compared to the baseline levels of UPR targets in cultured cells, their maximal levels
after tunicamycin exposure, or their relative fold induction, the strongest correlation was
obtained with the maximal levels of UPR target genes (Figure 2.10a). The corresponding
baseline levels were correlated with HDL and total cholesterol levels in both GRP94 and
BiP. Interestingly, relative calnexin expression in tunicamycin-treated cells was signific-
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Figure 2.10: The UPR profile as recorded in primary fibroblasts is positively correlated with plasma lipid levels. A. R values
(from Pearson correlation; * = P<0.05) between prior (baseline), after tunicamycin exposure (maximal), and ratio max vs.
baseline (inducibility) for BiP, GRP94, Calnexin, or CHOP and lipid levels in the plasma of 4-5 month animals (n=15). Lipid
levels were assessed in animals receiving regular or high-fat/sucrose diet for 2 weeks. B. Representative examples of correlation
between total cholesterol (chol) before (pre) or after (post) high-fat diet administration and BiP, GRP94, and CHOP in pubertal
fibroblasts after exposure to tunicamycin. *=P<0.01, Pearson’s). (Adapted with permission from Havighorst et al., 2019)

antly correlated with HDL and total cholesterol levels, but this was not the case with the
other tested UPR targets.
In challenged animals that had received high-fat diet for 2 weeks, plasma lipid
levels increased (Figure 2.11g), but BiP levels in culture ceased to be associated with
lipid levels in the plasma as they were prior to diet-induced challenge (Figure 2.10).
However, the maximal levels of CHOP and calnexin levels continued –with the exception
of calnexin and HDL - to show association with the plasma lipid levels in the same way
as they did prior to high-fat diet administration. It is possible that while BiP is mostly
associated with basal lipid metabolism, under conditions of metabolic challenge CHOP
and calnexin are engaged more. A role in promoting lipid accumulation has been
demonstrated for CHOP (Rutkowski et al., 2008); however, we are unaware of a similar
association between calnexin and lipogenesis.
THE PROFILE OF BIP EXPRESSION IN CULTURED CELLS IS DISTINCT IN
HIGH-ALTITUDE DEER MICE
Adaptation at high altitudes involves reprogramming of the animals’ metabolic
program to satisfy, among other demands, the elevated demands for thermogenesis and
insulation (Havighorst et al., 2019). Therefore, we explored if the differences in the UPR
profile recorded in P. maniculatus have ramifications in the adaptation to different
environments. Analysis of animals from a colony established in the past from ancestors
captured at high altitudes (SM2 population) (Vrana et al., 2014) showed that, in general,
these animals exhibited more intense UPR than the low altitude population (BW
animals), as evaluated by the number of genes that are in the top 50 th, 25th or 5th
percentile of the combined BW and SM2 population (Figure 2.11).
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Figure 2.11: Differences in the UPR profile in primary fibroblasts between high
(SM2 population, n=24) and low (BW population, n=61) altitude deer mice. a.
Percentage of animals in each of the SM2 or BW populations that have at least 1 UPR
gene in the highest 50th percentile of the total population. P value is shown (chisquare test). b. Percentage of animals in each of the SM2 or BW populations that
have all 4 UPR genes in the highest 25th percentile of the total population. P value is
shown (chi-square test). c. Percentage of animals in each of the SM2 or BW
populations that have 3 or 4 UPR genes in the highest 5th percentile of the total
population. P value is shown (chi-square test). The corresponding distribution for the
number of genes in each analysis is shown in d, e and f, on the right panel. For these
analyses maximal expression was considered. g. Average lipid levels in SM2 (n=5) or
BW (n=10) prior to or after high-fat diet administration for 2 weeks. P values
(students t-test) are shown. (Adapted with permission from Havighorst et al., 2019)
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For this analysis the percentage of animals in each of the SM2 or BW populations
that have at least 1 UPR gene in the highest 50th percentile (Figure 2.11a), that have all 4
UPR genes in the highest 25th percentile (Figure 2.11b), or that have 3 or 4 UPR genes in
the highest 5th percentile (Figure 2.11c) of the total population are shown. The
corresponding distribution for the number of genes in each analysis is shown in Figure
2.11d, Figure 2.11e and Figure 2.11f, respectively.
In view of the positive correlation between UPR genes and plasma lipids, a
testable hypothesis is that high altitude animals had elevated plasma levels of lipids.
Indeed, the levels of LDL and to a lesser extent of total cholesterol – but not of HDL –
were elevated both prior to and after high-fat diet administration (Figure 2.11g). It is
plausible that enhanced UPR expression represents an adaptation that facilitates enhanced
lipogenesis at high altitude populations that in turn may satisfy the increased needs for
thermogenesis and insulation in rodents (Vaillancourt et al., 2009; Cheviron et al., 2012)
and humans (Temte 1996; Hirschler et al., 2012; Perrett et al., 2002).
THE UPR PROFILE EX VIVO PREDICTS HEPATIC STEATOSIS INDUCED BY
HIGH-FAT DIET
We subsequently tested if the profile of UPR ex vivo predicts the onset of chronic
diseases such as hepatic steatosis that are caused by long-term administration of high
fat/sucrose diet. Therefore, a cohort of animals, aged 3 months, whose UPR profile had
been recorded at puberty were subjected to high fat/sucrose diet for 6 months and
analyzed for evidence of fatty liver disease. Since UPR expression is generally
coordinated, this analysis involved animals exhibiting low coordination to facilitate
assessment of the individual genes’ predictive value. Although none developed diabetes,
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elevated baseline insulin levels, indicative of the onset of insulin resistance, were
positively associated with high baseline levels of GRP94 (not shown). Histopathological
analysis upon termination of the study showed that 50% of the animals exhibited
steatosis, occasionally associated with portal inflammation of variable degrees (Figure
2.12a,b) that was correlated with the baseline levels of calnexin in the fibroblasts
(P=0.045) (Figure 2.12c). No lobar inflammation, ballooning degeneration of the
hepatocytes, or fibrosis of the stroma was observed. Analysis of steatosis onset, in
concert with GRP94 expression ex vivo, identified the latter as a protective factor for
disease development: The majority of the animals with steatosis (87.5%) had maximal
GRP94 levels in culture at the lower 50th percentile as opposed to only 12.5% of the
animals that developed steatosis and had maximal GRP94 at the higher 50 th percentile
(P=0.0027, chi-square test) (Figure 2.12c). It is to be noted that both baseline and
maximal levels of GRP94 exhibited positive correlation with HDL and total cholesterol –
but not LDL - levels prior to high-fat diet administration but this association was
abolished after 2 weeks of high fat/sucrose diet. As opposed to GRP94 that was
protective, high maximal BiP expression (P=0.017) in fibroblasts and inducibility of
CHOP (P=0.033) were predictive for higher sensitivity to steatosis (Figure 2.12). To that
end, the increased incidence of steatosis in the animals with higher BiP expression could
be the trade–off for the enhanced lipogenesis that may be beneficial at high altitudes.
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Figure 2.12: Long-term administration of high-fat diet causes metabolic pathologies at
variable degree in P. maniculatus (n=16). a. Macroscopic and necropsy images
showing animals with minimal (upper panel) or high (lower panel) fat accumulation
after administration of high fat/sucrose diet for 6 months. b. H&E –stained sections of
livers from mice showing minimal or no evidence of pathology (upper panel), high
degree of hepatic steatosis (lower left) or portal inflammation (lower right). Yellow
arrows indicate cells accumulating high amount of fat and yellow asterisks indicate
portal inflammation. c. Correlation between steatosis (recorded in 8 out of 16 animals)
or portal inflammation (recorded in 8 out of 16 animals) and whether the expression of
the corresponding UPR-related gene was assigned to the top 50th (H50) or bottom 50th
(L50) percentile in the animals tested. P values (chi-square test are indicated).
(Adapted with permission from Havighorst et al., 2019)
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ACTIVATION OF UPR AND VARIABLE SENSITIVITY TO STEATOSIS IN P.
MANICULATUS THAT RECEIVED HIGH-FAT DIET FOR 6 MONTHS
Initially we explored if outbred deer mice are sensitive to diet-induced hepatic
steatosis. To that end, animals were given a high-fat, high-sucrose diet for 2 weeks or 6
months and monitored the onset of pathology in the liver. While high-fat diet for 2 weeks
did not cause pathology, prolonged high-fat diet administration for 6 months resulted in
the development of hepatic steatosis in about half of the animals (6 out of 13) (Figure
2.13). No lobar inflammation, ballooning degeneration of the hepatocytes, or fibrosis of
the stroma was observed. Then we analyzed the hepatic expression levels of UPR genes
BiP, GRP94, calnexin and CHOP, of enzymes linked to lipid metabolism: hepatic lipase
(HL) (Perrett et al., 2002), LDL receptor (LDLR) (Rudling et al., 1990) and autophagy
genes LAMP1 (Eskelinen 2006), ATG5 (Rouschop et al., 2010) and ATG14 (Zhao et al.,
2015). Both males and females (about 50% each) were included in both groups but no
gender-specific differences were recorded. Comparison in the hepatic expression of the
UPR genes between experimental groups showed that only CHOP was significantly
upregulated in all groups that received HFD for 6 months as compared to those that
received it for 2 weeks only (Figure 2.14). Similar profile was exhibited by LDLR and
LAMP1 while HL was overexpressed in the animals that received HFD for six months
but did not developed steatosis (Figure 2.14). No considerable difference was observed
between the animals that developed steatosis and those that did not, which suggests that
the upregulation of these transcripts is a consequence of the lipid-rich diet and not of
steatosis. Not surprisingly, high variation in the levels of genes’ expression was recorded
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Figure 2.13: H&E stained sections of liver parenchyma showing intracytoplasmic
accumulation of lipids in hepatocytes. In the upper panel, a specimen with only a few
cells having fat vacuoles is shown while in the lower panel, a specimen with most of the
cells having fat vacuoles is shown, indicative of extensive liver steatosis.
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Figure 2.14: Hepatic expression of UPR genes BiP, GRP94, Calnexin and CHOP,
lipid metabolism enzyme hepatic lipase (HL), LDL receptor (LDLR) and autophagy
genes LAMP1, ATG5, and ATG14 in animals that received the high-fat diet for 2
weeks (n=14) or 6 months (n=13). Expression levels in animals that received HFD
for 6ix months and developed or did not develop steatosis are shown. P values (oneway ANOVA by applying Tukey’s multiple comparison test) between experimental
groups are shown. Error bars indicate SEM.
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between the different animals which is due to their genetic heterogeneity and the
stochastic nature of disease development.
COORDINATION OF CHAPERONE EXPRESSION IS MAINTAINED DURING
HIGH-FAT DIET ADMINISTRATION
The UPR is a concerted cellular response that engages multiple biochemical
pathways simultaneously. Therefore, it is conceivable that the levels of each individual
chaperones will be correlated, regardless of their differential intensity between individual
animals. To test this hypothesis we performed pairwise comparisons in the expression
levels of UPR genes in animals that had received high-fat diet for 2 weeks and 6 months.
A summary of the results is shown in Figure 2.15. After only 2 weeks in the high-fat diet
a high degree of correlation was attained for all pairwise comparisons of the chaperones
tested between BiP, GRP94 and calnexin, and this correlation was maintained in the
livers of animals that received a high-fat diet for 6 months. Thus, although long term
administration of high-fat diet and thus of ER stress induction can modulate individual
chaperones’ expression, their coordination is retained. The expression of CHOP was not
coordinated with any of the chaperones tested (Figure 2.16) despite that its overall
expression was significantly elevated.
UPR GENES EXHIBIT A DISTINCT PROFILE OF COORDINATION WITH
LIPOPHAGYMARKERS, LIPID METABOLISM ENZYMES DURING HIGH-FAT
DIET ADMINISTRATION
Because UPR is associated with both lipophagy and lipid metabolism, we
assessed if the expression of ATG5, ATG14 and LAMP1 (autophagy markers, Figure
2.17) or HL and LDLR (lipid metabolism, Figure 2.18) is coordinated. The analysis
showed that among the autophagy markers ATG5 was coordinated with the expression of
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Figure 2.15: Correlation in the hepatic expression between BiP, GRP94 and
Calnexin in animals that received high-fat diet for 2 weeks (n=14) (a) or 6 months
(b) (n=13). High correlation is attained in both the 2 weeks and the 6 months-treated
groups. Each dot corresponds to a different animal. Levels of each transcript are
expressed in arbitrary units following normalization with GAPDH. R values are
shown. All correlations were significant (P<0.05, Pearson’s correlation).
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Figure 2.16: Correlation in the hepatic expression between CHOP and each of BiP,
GRP94 and Canexin in animals that received high-fat diet for 2 weeks (n=14) (a) or
6 months (b) (n=13). Although a positive trend can be recognized statistical
significance was not attained.
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Figure 2.17: Hepatic expression of UPR genes BiP and GRP94 in relation to
lipophagy markers ATG5, ATG14 or LAMP1 in animals that received high-fat diet
for 2 weeks (n=14) (upper panel) or 6 months (n=13) (lower panel). Levels of each
transcript are expressed in arbitrary units following normalization with GAPDH. Only
ATG5 exhibited positive correlation with both BiP and GRP94 (P<0.05, Pearson’s).
R values are shown.
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Figure 2.18: Hepatic expression of UPR genes BiP and GRP94 in relation to HL
and LDLR in animals that received high-fat diet for 2 weeks (n=14) (upper panel)
or 6 months (n=13) (lower panel). Levels of each transcript are expressed in
arbitrary units following normalization with GAPDH. Positive correlation was
recorded for HL in 6 months (P<0.05, Pearson’s). R values are shown.
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either BiP or GRP94 (as well as calnexin, not shown) in both the 2 weeks and the 6
months high-fat diet group (Pearson’s, P<0.05).
Of the lipid metabolism genes, HL was expressed in a coordinated manner with
both BiP and GRP94 both in the 2 weeks and the 6 months high-fat diet group and
attained significance in the latter (P<0.05, Pearson’s).
HL ABOLISHES ITS COORDINATION WITH UPR GENES ONLY IN THE
STEATOSIS GROUP
The fact that the 6 months high-fat diet group included both animals that developed
steatosis (n=6) and animals that did not (n=7), in combination with the fact that some
differences were seen in the group that received the high-fat diet for 2 weeks or 6 months
raised the possibility that the heterogeneity in pathology may contribute to the variation
in the coordination profiles recorded. To explore this possibility further we assessed the
extent of coordination, independently in the steatosis and the non-steatosis group in
comparison with that of the 2 weeks group (n=14) and the 6 months group cumulatively
(n=13). For this analysis we used Spearman’s correlation that is more appropriate for
monotonic relationships especially when small number of samples are included. The
results are shown in Figure 2.19. UPR genes retained their correlation profile in all
groups tested, regardless of whether steatosis developed (Figure 2.19). The same pattern
was also exhibited by ATG5 that had positive correlation with the UPR genes in all
experimental groups. LDLR did not show any evidence of correlated expression in any of
the groups studied suggesting that despite its upregulation in the long term HFD-group
(Figure 2.14), its regulation is independent of the UPR and does not signify steatosis
development. Interestingly, HL and LAMP1 retained a positive correlation with UPR that
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was however reversed in the livers with steatosis. ATG14 exhibited the reverse profile,
albeit at a lesser extent, as livers without steatosis after 6 month HFD administration
showed reduced coordination with the UPR.
HL IS INHIBITED BY ER STRESS
The inverse correlation of LAMP1 with UPR genes only in the steatosis group is
not surprising considering that LAMP1 is a lysosomal marker and that lipophagy is
generally impaired in steatosis (Andruska et al., 2015; Kooptiwut et al., 2014; Vrana et
al., 2014). With HL however, this association (Figure 2.20a) was intriguing in view of the
controversial of this enzyme in steatosis development (Chiu et al., 2010; Andres-Blasco
et al., 2015). To test if HL is regulated by ER stress, rat hepatoma (H-411-EC3) cells
were exposed to tunicamycin (2.5ug/uL or 5ug/uL), and chaperone expression as well as
expression of HL were evaluated. As expected BiP, GRP94, CNX and CHOP were
activated during both 5h and 24h tunicamycin treatment confirming that canonical UPR
is induced (Figure 2.20b). Under these conditions, HL exhibited a moderate induction at
5h, but a strong reduction at 24h. This reduction was apparently dose dependent, with
greater decrease occurring with 5ug/usL than with 2.5ug/uL tunicamycin (Figure 2.20c).
We may postulate that longer exposure to tunicamycin induces severe ER stress which in
turn mimics the state of the steatotic livers in which negative correlation between HL and
UPR genes was recorded. However, under short-term exposure to tunicamycin – when
presumably ER stress is mild – a moderate activation of HL is seen which simulates the
state of the livers without steatosis.
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Figure 2.19: Correlation matrix in the hepatic expression between BiP, GRP94,
Canexin, CHOP, LAMP1, ATG5, ATG14, HL, and LDLR in the livers of animals
that received lipid-rich diet for 2 weeks (n=14) (a), 6 months cumulatively (n=13)
(b), only those that did not developed steatosis (n=6) (c) and those that did (n=7)
(d). R values (correlation coefficient) from Spearman’s correlation are shown (*,
P<0.05). Yellow and red squares outline genes that respectively retained or
abolished their coordination with the UPR genes in the livers with or without
steatosis.
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Figure 2.20: Regulation of HL by ER stress. a. Opposite correlation between HL and
UPR genes in livers with and without steatosis. b. Expression of BiP, GRP94, CNX
and CHOP in H-411-EC3 cells exposed to tunicamycin (0 or 5 ug/ml) for 5h or 24h. c.
Dose-dependent inhibition of HL expression during ER stress. Results had been
normalized with GAPDH and are expressed in arbitrary values (AU).
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CHAPTER 3: DISCUSSION
While the linearity in the expression of UPR-associated genes has been studied
extensively by induced qualitative changes in gene expression, whether the response to
ER stress exhibits coordination and variability among individuals remains inadequately
studied. In the present study, we used genetically diverse deer mice as a model to record
the profile of the UPR in cultured primary cells isolated at puberty. Our analyses showed
that UPR induction at the mRNA level was highly variable between different animals, yet
a high degree of coordination was maintained in the expression levels of individual
targets; some animals exhibited a more intense response to ER stress while others
displayed a milder response. The importance of this difference in the adaptation of
animals in different environments is suggested by the observation that the high-altitudeoriginating SM2 stock of deer mice exhibit a more intense UPR than the low-altitudeoriginating BW stock. This tendency was apparent regardless of the cut-off of the gene
number that were considered. It is noted, though, that this association may reflect founder
effects during the establishment of SM2 colonies of P. maniculatus. To eliminate this
possibility, wild caught animals should also be used to validate this finding. Nonetheless,
the presence of different alleles with regards to the polymorphisms in BiP promoter
between the 2 different stocks supports the notion that the populations are genetically
distinct and that certain differences in the regulatory regions of UPR genes such as BiP
may contribute to the distinct profile of the UPR in these stocks (Havighorst et al., 2019)

50

Whether the UPR variation observed in vitro reflects varying efficiency of protein
folding, or an altered response during challenge, remains unknown. Although neither
possibility can be excluded formally, our data are mostly aligned with the latter
possibility. We postulate that if the differences recorded here were primarily due to the
inherent, varied ability of the individuals for protein folding, then no association between
baseline expression and maximal expression would have been recorded, since the
baseline levels would be assumed to be different but the maximal levels should have
remained similar. In addition, fibroblasts were analyzed in vitro, after multiple passages
in the petri dish, decreasing the possibility that systemic factors might have caused the
differences recorded. Formally, the possibility that systemic factors might have caused
epigenetic changes in the fibroblasts cannot be ruled out, but this appears rather unlikely.
In order to systematically though address this, experiments should be designed to assess
the abundance of misfolded proteins independently of UPR induction and then test if and
at which extent they (UPR genes’ levels and accumulated unfolded proteins) correlate
with each other.
The availability of individual animals with variable response to UPR allowed us
to explore if inherent variation in UPR is associated with metabolic disease and
deregulation of lipid homeostasis, conditions that are highly relevant to ER stress.
Therefore, we assessed the animals’ blood glucose on a weekly basis, and additionally
assessed the animals’ lipid levels both prior to and after high fat diet administration.
While the animals did not become diabetic, we did observe an apparent difference in the
abilities of high and low responders to maintain a stable blood glucose, which high
responders appeared to do far more effectively. Additionally, we noted a shift in
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correlation between GRP94/Cnx expression and blood glucose; this is likely a reflection
of the increasing stress and metabolic changes occurring due to high-fat diet. It is noted
that although isoflurane in known to induce hyperglycemia, administration of isoflurane
is unlikely to have affected our results, as animals were not exposed to isoflurane except
immediately prior to sacrifice. Weekly blood collections were performed without
anesthetic of any sort, and blood collected for lipid analysis was collected via
submandibular puncture prior to anesthesia and subsequent sacrifice. Additionally,
isoflurane was applied to the lipid profile control groups as well, which were
unchallenged and should not have exhibited alterations to their cholesterol profile. It is
emphasized that the administration of the high fat diet occurred in adults, beginning two
months after the characterization of the fibroblasts that occurred at puberty. Our results
suggest that the UPR profile of cultured fibroblasts isolated early in life is linked to the
onset of metabolic pathologies at the organismal level. With regards to the lipid levels in
the plasma, the ex vivo levels of all 4 genes tested showed, independently, a positive
association with the baseline plasma lipid levels underscoring the link between ER stress
and lipid metabolism. After high-fat diet administration, this association persisted only
for CHOP and calnexin, implying that these UPR genes increase in expression
particularly after diet-induced stress.
Prolonged administration of high-fat diet and induction of steatosis in a subset of
the animals facilitated assessment of the predictive value of individual UPR-associated
genes in disease development. This considerable variation in steatosis development is
seen only in the outbred Peromyscus used here because in laboratory mice, prolonged
administration of high fat diet, albeit variably among different inbred strains, induces
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steatosis rather uniformly within the animals of the same strain while some variation
exists only to the portion of the liver exhibiting evidence of disease (Rudling et al., 1990;
Eskelinen 2006; Rouschop et al., 2010; Zhao et al., 2015).
Animals for which UPR genes were not coordinated, especially BiP and GRP94,
were subjected to a high-fat diet; this allowed us to appreciate the contribution of each
individual gene. Analysis showed that the UPR profile in fibroblasts collected early in the
animal’s life could be used to predict the animal’s susceptibility to diet-induced hepatic
steatosis. An intriguing finding was the protective role of GRP94 against steatosis,
despite the positive association of this gene with plasma lipid levels, implying the
operation of a predictive factor capable of dissociating hyperlipidemia with hepatic
disease. A role for GRP94 in suppressing liver cancer has been proposed (Chen and
Tseng et al., 2014; Chiu et al., 2010), but no evidence for the direct involvement of
GRP94 in hepatic steatosis is available, which may point to a novel action of this
chaperone in lipid metabolism.
With regards to BiP, our analysis showed that higher BiP expression in the
fibroblasts was associated with an increased risk of developing hepatic steatosis. It is
noteworthy that the specific deletion of BiP in hepatocytes promotes steatosis in
laboratory mice (Mus), implying a protective role for BiP in disease development (Ji et
al., 2011; Chen and Zhu et al., 2014). It is conceivable that this contradiction reflects the
pleiotropy of BiP function and its cumulative role in lipid metabolism beyond the liver.
Enhanced expression of BiP in the liver may thus be protective, as pointed out by the
mouse studies. However, this benefit could be counteracted by its presumably negative
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role in other peripheral tissues. Consistent with this observation, it has been demonstrated
that systemic administration of chemical chaperones alleviates hepatic steatosis in rodent
models of the disease (Andres-Blasco et al., 2015). Furthermore, the transcription factor
XBP1 that is activated during the UPR has been shown to possess lipogenic activity
(Chiu et al., 2010), even though an anti-lipogenic role has also been shown (Rouschop et
al., 2010). Another plausible explanation is that the genetic ablation of BiP in vivo
produces phenotypes that may be qualitatively distinct from the reduction of BiP
expression over time in response to the high-fat diet, as we observed in the genetically
diverse experimental animals used here. The cascade of events triggered by the deletion
of BiP and other UPR-associated genes in mice may cause phenotypic manifestations that
are not highly relevant to the naturally occurring versions of hypomorphic BiP alleles
seen in deer mice, or to physiological alterations to BiP expression which occur due to
challenge (Havighorst et al., 2019). This may also explain the apparent discrepancy that,
depending on the model, both lipogenic and antilipogenic activities for the same UPR
gene may be revealed (Lee et al., 2008; Herrema et al., 2016).
We found calnexin’s involvement to be intriguing. While it exhibited a similar
predictive activity to CHOP for lipidemia, no association with hepatic steatosis was
observed. It is likely that this reflects a shared regulation between CHOP and calnexin, or
a direct regulatory association between them during metabolic stress.
Whether the UPR variation observed here, which we recorded at the mRNA level,
also reflects similar variation at the protein level remains to be established.
Unfortunately, the absence of Peromyscus-specific antibodies or antibodies that
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adequately work on this genus to allow quantification of protein levels precludes this
analysis at this point. In addition, we note that mRNA levels as assessed here should
rather be viewed as indicators of differential activation of the UPR. Protein levels may or
may not directly follow changes to mRNA levels. However, in this case, an additional
level of complexity will be introduced: that of posttranslational modification which might
have masked the correlation between UPR gene expression and pathophysiological
parameters. As such, assessing protein levels may be useful for mechanistic studies
addressing the role of individual chaperones, yet activation of the UPR could not be
monitored accurately by evaluating protein levels.
We observed that different ER stress-linked genes were generally associated with
distinct parameters, either biochemical or histological. However, depending on the
specific gene-pathology combination, the highest correlations could be found in the
baseline, induction levels, or maximal levels. It is likely that while baseline levels reflect
a chronic stress state, exemplified by GRP94 and BiP levels, the inducibility and
especially maximal levels instead reflect acute stress and are exemplified by all 4 ER
stress-related genes analyzed here. The power of the protein processing machinery to
operate as a modifier of disease outcomes has been shown recently by the demonstration
that the activity of HSP90, the cytosolic paralogue of GRP94, determined the severity of
the cancer predisposition syndrome Fanconi anemia (Taipale et al., 2014).
Collectively, the ability of the UPR profile to predict the outcome of ER stressassociated pathologies later in life shows that the UPR intensity reflects a systemic
response rather than a reaction of isolated organs and tissues. It is also plausible that the
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organismic level responses recorded here to reflect the actual contribution of fibroblasts
that remain the most abundant cell type in the body. Nevertheless, it is conceivable that
by analyzing an appropriate selection of chaperones or combinations of UPR genes, the
onset of different ER stress-related pathologies may be predicted. It is likely that, by
using this platform consisting of different stressors in outbred populations, unforeseen
links between specific ER stress-associated genes and various diseases could be revealed.
Finally, the role of inherent variation of the UPR in the adaptation to different
environments needs to be elucidated.
In order to maintain homeostasis, cells respond to stressors by altering their
transcriptional profile in such a manner that the expression of genes that belong to the
same transcriptional networks remains coordinated. Therefore, changes in gene
expression affect not only an individual gene, but also any genes that might be coregulated along with it. It is conceivable that, during disease development, some
transcripts will deviate from this coordinated expression, including some that might be
causatively linked to the disease. This information could provide insight into disease
pathogenesis and also aid us in the identification of disease-relevant targets.
The present animal model also allows exploration with regards to the involvement
of UPR in the liver, in

the pathogenesis of hepatic steatosis. By using outbred,

genetically diverse deer mice as our model, and by placing them on a high-fat diet for a
short period of time or long term, under conditions in which only a fraction of the
animals developed hepatic steatosis (Untergasser et al., 2012) we analyzed the UPR in
the liver. We hypothesized that liver samples from these groups would respectively
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reflect conditions of short-term stress, chronic stress but with homeostasis maintained (no
steatosis), and ultimately chronic stress when homeostasis is abolished and pathology
(steatosis) emerges. No animals receiving regular chow were included in the analyses
because they do not develop steatosis (not shown), their ER is unchallenged, and UPR is
minimal. Because our analysis focused on differences between steatotic and nonsteatotic
animals exposed to identical conditions, we postulated that analysis of coordination in
gene expression in control animals would be meaningless.
We performed our studies in outbred deer mice as opposed to conventional inbred
mice to be able to record the degree of coordination and eventually the loss of such
coordination in a genetically diverse wild type population. The transcriptional analyses
involved a panel of genes associated with the UPR, a nodal transcriptional response
pathway with an established relationship with liver dysfunction and hepatic steatosis, and
genes linked to either liver metabolism (LDLR, HL) or lipophagy (LAMP1, ATG5 and
ATG14). In the absence of reliable Peromyscus-specific antibodies, quantification of
protein levels could not be performed. However, mRNA levels should rather be viewed
as precise indicators of differential activation of the UPR and thus assessing them
provides reliable means to evaluate its differential profile in different individuals.
Our analysis showed that, compared to the short-term high-fat diet administration,
long-term high-fat diet caused a significant activation of CHOP as well as of LAMP1,
HL and LDLR. Yet, high variation in gene expression was recorded, which is likely due
to the genetic diversity of the animal model. Importantly, no differences in the expression
levels between the livers that developed steatosis and those that did not were recorded
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suggesting that expression levels of individual transcripts are unable to discriminate the
disease.
However, when expression was co-analyzed for different transcripts, we realized
that the activation of the UPR shortly after the induction of high-fat diet-induced stress is
characterized by a coordinated expression of the various chaperones which retain their
ability to respond proportionally, though variably, in the different animals tested. This
coordination was maintained in conditions of prolonged exposure, despite the fact that
differences in the profile of coordination could be seen. Specifically, a weak trend for
loss of coordination was unveiled between the short-term diet group and that of long-term
administration. In the latter group, however, animals with and without steatosis were
included in the same analysis with no difference in the trends observed between these
groups. Under these conditions, CHOP exhibited the weakest coordination with the other
UPR-associated genes, an observation that probably reflects the complex regulation of
this transcription factor beyond ER stress.
Of the lipophagy markers, only ATG5 was coordinated with UPR genes GRP94
and BiP, and this profile was maintained regardless of disease onset. LAMP1, despite
being consistently upregulated under long-term high-fat diet, exhibited only insignificant
coordination with the UPR implying that unlike ATG5 and ATG14, regulation of
LAMP1 is not tightly linked to ER stress. Similarly, of the genes associated with lipid
metabolism, only HL showed coordination with both BiP and GRP94, implying a
potential causative link between this enzyme and the UPR. The specific role HL in
steatosis progression, especially in the context of ER stress induction is further marked by
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its loss of coordination with UPR genes in the specimens that developed steatosis.
Comparison of the degree of coordination between all lipophagy and lipid metabolism
genes with the UPR-associated genes in the livers that received high-fat diet showed that
HL was the only gene that exhibited consistently high coordination, and that this
coordination was lost and indeed reversed, only in the specimens that developed steatosis.
Thus, it is not the chronic administration of the high-fat diet that is linked to this loss of
coordination, but rather the development of steatosis. Therefore, we hypothesize that HL
is regulated by the UPR only in the context of homeostasis, but this association is lost
when pathology emerges. In line with this notion are previous observations in genetically
modified mice at which genetic ablation of HL may result in opposing findings with
regards to steatosis according to which both a protective and promoting role has been
reported (28,29). To that end it is conceivable that it is not the activity of HL that is
linked to steatosis but rather its degree of coordination with the UPR and other possible
targets, that depending on the experimental system may be associated with both induction
and inhibition of ER stress, shifting its coordination with HL to either direction.
We further validated the regulation of HL during ER stress by exposing
hepatocytes to tunicamycin, which showed that prolonged treatment inhibited HL
expression, while UPR target genes were induced. We postulate that during short-term
exposure, when ER stress is moderately activated, the hepatocytes initiate the adaptive
UPR that retains homeostasis and thus HL is co-induced with the UPR target genes, a
state that simulates that of the liver tissues in animals without steatosis. When steatosis
develops and homeostasis is abolished, on the other hand, the activation of HL by the
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UPR is lost, as happens with the hepatocytes in culture at which HL is inhibited during
prolonged ER stress.
These results have important implications in disease management suggesting that
at least for complex multifactorial diseases, instead of pursuing specific targets for
therapeutic intervention it is rather their relative abundance, in concert with other
members of the biochemical response in question, that bears value as a disease causing
agent. Because this balance seems to be important, it may actually do more harm to
inhibit specific UPR-related genes, even if said gene has been experimentally linked to a
disease; in fact, doing so may itself lead to the development of disease.
It is conceivable that analyses such as the one described here, towards more
disease entities and additional gene targets, may be useful in assembling detailed gene
networks and demonstrating how their deregulation is abolished during disease
pathogenesis. Such an approach may be particularly useful in developing innovative
therapeutic strategies, in assembling transcriptional networks and elucidating how they
operate in physiology and pathology, and in assigning particular transcripts to given
biochemical responses.
Collectively, the present study explored for the first time the regulation of the
UPR in a genetically diverse population and evaluated the implications of this regulation
and of its dysregulation in metabolic diseases, like hepatic steatosis. Findings of the
present research will likely find application in biomedical research.
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CHAPTER 4: METHODS AND MATERIALS

FIBROBLAST CULTURE AND TUNICAMYCIN TREATMENT
Fibroblasts were isolated from ear punches collected from juvenile mice during
routine weaning and marking procedures at the Peromyscus Genetic Stock Center
(PGSC). These ear punches were washed for 2 minutes in 2mL 70% EtOH (Decon)
before being placed in 1mL sterile RPMI-1640 + 10% FBS + 500 u/mL Penicillin + 500
uL/mL + .292mg/mL L-Glutamine (all HyClone) (hereafter “complete RPMI”), which
had previously been aliquoted into sterile 1.5mL tubes under a hood, ensuring sterility
until tissue collection. Ear punches were macerated using sterile surgical blades
(GLASSVAN; blade size 24) andtreated with 1mL collagenase I (Sigma-Aldrich,
100U/ml) dissolved in plain RPMI for 1 hour. After 1 hour, the collagenase in the media
was inactivated by the addition of complete RPMI (at least 2mL per mL collagenase
solution). The following day, an additional 2mL of complete RPMI was added to boost
the concentration of FBS in the culture. Remaining tissue fragments were removed via
vaccuum from the culture once cells were visible, typically three days following
collagenase treatment, during media change. Cells were subsequently cultured in
complete RPMI. For cell passage, we removed old media, washed the cells with sterile
PBS, then treated them with porcine trypsin (HyClone) for 5 minutes when cells were at
90% confluency or above. They were then passed to larger plates, without discarding any
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cells, to 45% confluency or above. Fibroblasts were passed no more than 5 times before
tunicamycin treatment, with the exception of cells used for the high-passage control,
which were treated at passages 2 and 6. For tunicamycin treatment, cells were split into
6-well plates (VWR) at 300,000 cells/well, and left for 24 hours to recover. After 24
hours, tunicamycin (Sigma-Aldrich) dissolved in DMSO (Sigma-Aldrich) was added to
the media to a concentration of 5ug/mL for 5 hours, immediately followed by RNA
extraction (procedure described below). For thapsigargin treatments, an identical
procedure was followed, with the exception of the addition of thapsigargin (SigmaAldrich) dissolved in DMSO to a concentration of 1μΜ.
H-411-EC3 rat hepatoma cells (courtesy of Karen Barbour, USC Department of
Biological Sciences, Center for Colon Cancer Research) were cultured using MEM
(Corning) + 10% FBS + 500 u/mL Penicillin + 500 ug/mL Streptomycin + .292mg/mL
L-Glutamine + 5mL essential amino acid solution (Corning) (“complete MEM”), and
passed when cells were at 90% confluency or above to 45% confluency or above,
discarding extra cells as necessary. Cells were treated at passage 9-10. For tunicamycin
treatment, cells were split into 6-well plates, 300,000 cells/well, and left for 48 hours.
After 48 hours, tunicamycin was added to the media to a concentration of 2.5-5ug/mL for
5 hours or 24 hours, immediately followed by RNA extraction.
ANIMALS
Deer mice (Peromyscus maniculatus) were obtained at the time of weaning from
the Peromyscus Genetic Stock Center (USC), Columbia, SC (RRID:SCR_002769).
Treatment beyond fibroblast collection was not started until animals were 3 to 4 months
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old. At that age, animals were placed on a high-fat diet (58% kcal/fat with sucrose,
Research Diets D12331), with the food being monitored and changed or replenished at
least weekly or as necessary, for 2 weeks or 6 months. After the specified durations, the
animals were sacrificed using isoflurane (Thermo-Fisher) as an anesthetic followed by
cervical dislocation, and the pancreas, liver, kidneys, muscle, and adipose tissue were
excised, in that exact order, to minimize the breakdown of delicate and sensitive tissues
as much as possible. Tissues for RNA were immediately frozen using dry ice. Tissues for
histology were placed in and left in 10% neutral buffered formalin (VWR) for two days
before replacement with an equal amount of 100% EtOH (Decon). The study was
approved by the IACUC from the University of South Carolina.
BLOOD GLUCOSE AND BODY WEIGHT MEASUREMENT
Following a 6h fast but prior to blood glucose assessment, each animal was placed
in a container and its weight recorded. Immediately following this, we assessed the blood
glucose of animals in the six-month treatment group via tail vein puncture using a 30g
needle (BD). Animals were handled in such a manner that the tail could be held firmly in
a position which facilitated tail vein puncture and subsequent blood collection. If
moisture was present on the tail, it was thoroughly dried prior to collection to prevent
contamination and loss of blood samples due to wicking of the blood droplet. Following
puncture, any excess blood was removed by paper towel; additionally, if bleeding
persisted, light pressure was applied to the puncture site until bleeding had stopped.
Blood glucose was measured using a glucometer once weekly for six months.
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RNA EXTRACTION, CDNA SYNTHESIS, AND QPCR
RNA extraction was initially performed using the RNeasy Mini Kit (QIAgen),
using the supplied protocol, with modifications. Spin time for the wash steps was
increased from 15s to 30s. The extra spin step prior to elution was included. RNA was
eluted using 30uL nuclease-free water. This was later changed to All-In-One DNA/RNA
Miniprep Kit (BioBasic) due to greater RNA yield and quality with the latter kit. In all
cases, cDNA synthesis was performed using the iScript cDNA synthesis kit (Bio-Rad)
according to the supplied protocol. qPCR was performed on the T100 thermocycler (BioRad) using iTaq Universal SYBR Green supermix (Bio-Rad). Oligonucleotide sequences
used for qPCR amplification were designed using Primer3 and PrimerBLAST and are
shown in Table 4.01.
CHOLESTEROL MEASUREMENT
Following a 6-hour fast, blood for cholesterol measurement was collected from
animals via submandibular puncture. This was performed once before high-fat diet
administration, and once immediately prior to sacrifice. Blood samples were captured
using BD Microtainer tubes, incubated at room temperature for 30-45 minutes, then
centrifuged at 10,000rpm for 5 minutes to isolate serum. Regardless of circumstances, all
isolated serum was frozen at -80°C prior to use to ensure that all samples had been treated
identically. Cholesterol was measured using an HDL and LDL/VLDL Cholesterol Assay
Kit (Abcam). The procedure was followed as provided with the kit, without modification.

64

HISTOLOGY
At sacrifice, liver was excised from each animal, fixed using 10% neutral buffered
formalin (VWR) for two days, dehydrated with 100% EtOH, and embedded in wax.
Paraffin sections were stained with hematoxylin and eosin (H&E). Histological
examination of the liver specimens was performed blindly for the presence of
nonalcoholic fatty liver disease (NAFLD) according to the scoring system designed by
the Pathology Committee of the NASH Clinical Research Network, which addresses the
full spectrum of lesions of NAFLD (Kleiner et al., 2005). Images shown were obtained
by a Leica ICC50 HD.
STATISTICAL ANALYSIS
Correlations between genes were analyzed by using a two-tailed Student’s t-test,
Pearson’s correlation, or Spearman’s correlation. All analyses were performed either in
Microsoft Excel, or using GraphPad Prism 8 software (San Diego, CA). P values are
shown in the results or Figures and were considered significant if P<0.05. Coordination
between genes was analyzed by using one-way ANOVA and applying Tukey’s multiple
comparison test.
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Peromyscus qPCR Primers
Length Temp GC% Self-Comp (5', 3')
For 20
59
55
3, 1
Amplicon Length: 108
Rev 20
58.9 50
4, 2

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_001163434.1 XM_006988727.1 94%
97%

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
59.2 55
4, 0
Amplicon Length: 154
20
59.1 50
4, 3

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_011631.1 XM_006979864.1 91%
99%

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58.9 50
3, 3
Amplicon Length: 118
20
59.1 55
4, 2

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_001110499.1 XM_006987088.1 90%
96%

TCGCTCTCCAGATTCCAGTC
GTTCCTTCTCCTTCATGCGC

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58.9 55
4, 2
Amplicon Length: 131
20
59.3 55
4, 4

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_001290183.1 XM_006973295.1 88%
61%

P. maniculatus LDLR, qRT
GGCCCAACAAGTTCAAGTGT
CACCATTGTTGTCCAAGCAC

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58
50
4, 3
Amplicon Length: 138
20
58
50
5, 2

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
78%
NM_001252658.1 XM_006982333.2 88%

P. maniculatus LIPC/HL, qRT
GACTCCTTGCGACACAGTGA
CGGATGTCATAGCCCAGAGT

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58
55
5, 3
Amplicon Length: 125
20
58
55
5, 1

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
89%
NM_001324472.1 XM_015997939.1 89%

P. maniculatus LPL, qRT
GCCACCTCATTCCTGGAGTA
GGCACCCAACTCTCGTACAT

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
59
55
5, 3
Amplicon Length: 118
20
59
55
4, 2

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_008509.2 XM_006989568.2 87%
88%

P. maniculatus LAMP1, qRT
ACTGGTGAAAACGGAACCTG
CCATGAGCTGTGTCATTTGG

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58 50%
3, 1
Amplicon Length: 125
20
57 50%
4, 0

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_001317353.1 XM_015999785.1 85%
87%

P. maniculatus ATG5, qRT
TGCCGTCCTTAAACCTCAAC
AGGGCTTCAGCTGCATGTAT

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
58
50
4, 0
20
59
50
6, 2

Amplicon Length: 82

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
92%
83%
XM_011243108.2 XM_006996705.2

P. maniculatus ATG14, qRT
ACTCGTGCGGTGAAGAGACT
CCTGAGGGTATGCAGTGGTT

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
61
55
3, 3
20
59
55
5, 1

Amplicon Length: 96

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
48%
NM_172599.4 XM_016006027.1 92%

P. maniculatus BiP, qRT
CCAATGACCAGAATCGCCTG
TCCTGGTATCAATGCGCTCT

P. maniculatus GRP94, qRT
GAGGCCACAGAGAAGGAGTT
TCTCCATGTTGCCAGACCAT

P. maniculatus Calnexin, qRT
TTCTGACTGTAGCCTTGCCA
TCCTCCTTCACATCTGGCTG

P. maniculatus CHOP, qRT

P. maniculatus GAPDH, qRT
GTCGGAGTGAACGGATTTGG
GGTGGAGTCGTACTGGAACA

Rattus norvegicus BiP, qRT
TGCAGCAGGACATCAAGTTC
TTTCTTCTGGGGCAAATGTC

Length Temp GC% Self-Comp (5', 3')
20
58.9 55
3, 0
Amplicon Length: 141
20
59
55
4, 1
Rat qPCR Primers
Length Temp GC% Self-Comp (5', 3')
For 20
60
50
5, 3
Amplicon Length:
Rev 20
60
45
3, 2
111
For
Rev

Rattus norvegicus GRP94, qRT
TGATGATGAAGCCGCAGTAG
AAGTTCCCAGTCCCACACAG

Amplicon Length:
88

mRNA SEQUENCE USED

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
60
50
5, 3
20
60
45
3, 2

Amplicon Length:
99

mRNA SEQUENCE USED

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
60
50
5, 1
20
60
60
3, 0

Amplicon Length:
116

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
60
50
6, 2
20
60
55
4, 1

Amplicon Length:
98

mRNA SEQUENCE USED

For
Rev

Length Temp GC% Self-Comp (5', 3')
20
60
55
4, 0
20
60
50
4, 0

Amplicon Length:
85

mRNA SEQUENCE USED

Rattus norvegicus HL, qRT
TTGACTCCTTGCAACACAGC
GCCCTTCTTGCAGTTCAGAC

Rattus norvegicus GAPDH, qRT
TGCCACTCAGAAGACTGTGG
GGATGCAGGGATGATGTTCT

NM_013083.2

Length Temp GC% Self-Comp (5', 3')
20
60
50
3, 0
20
60
55
3, 1

Rattus norvegicus CHOP, qRT
CATGAACTGTTGGCATCACC
TCTACCCTCAGTCCCCTCCT

mRNA SEQUENCE USED

For
Rev

Rattus norvegicus Calnexin, qRT
CCTCAGATTGCCAACCCTAA
AGGCTTCCATTTGCCCTTAT

mRNA SEQUENCES USED
BLAST DATA
Mus Seq
Peromyscus Seq Identity Query Co
NM_001289726.1 XM_006992087.1 90%
92%

Table 4.01: List of primers used for qPCR analysis.
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NM_001012197.2

NM_172008.2

mRNA SEQUENCE USED
NM_001109986.1 (Var. 1)
(bp 151-813)

NM_012597.2

NM_017008.4
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